Park Ha Biological Technology Co., Ltd. Ordinary Shares

FRC's fair value estimate for Park Ha Biological Technology Co., Ltd. Ordinary Shares, and the rating behind it. BYAH last traded at $2.45; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Park Ha Biological Technology Co., Ltd. Ordinary Shares. Starting points for Park Ha Biological Technology Co., Ltd. Ordinary Shares: EPS -$13.27, beta 0.20 — an Household & Personal Products name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Park Ha Biological Technology Co., Ltd. Ordinary Shares. Park Ha Biological Technology Co., Ltd. Ordinary Shares does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Park Ha Biological Technology Co., Ltd. Ordinary Shares. Trailing twelve-month EPS for Park Ha Biological Technology Co., Ltd. Ordinary Shares stands at -$13.27. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Park Ha Biological Technology Co., Ltd. Ordinary Shares. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Park Ha Biological Technology Co., Ltd. Ordinary Shares valued side by side against its closest peers. Park Ha Biological Technology Co., Ltd. Ordinary Shares is measured against Household & Personal Products peers within the Consumer Defensive sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Park Ha Biological Technology Co., Ltd. Ordinary Shares, and how their positions are changing. At a $1.8M market value, institutional positions materially move Park Ha Biological Technology Co., Ltd. Ordinary Shares's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Park Ha Biological Technology Co., Ltd. Ordinary Shares executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Park Ha Biological Technology Co., Ltd. Ordinary Shares. Park Ha Biological Technology Co., Ltd. Ordinary Shares is a $1.8M Consumer Defensive company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Park Ha Biological Technology Co., Ltd. Ordinary Shares. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Park Ha Biological Technology Co., Ltd. Ordinary Shares. Coverage tracks Park Ha Biological Technology Co., Ltd. Ordinary Shares within Household & Personal Products (Consumer Defensive). Press releases and market coverage, newest first.